Thomas P Miller

  • 19247 Citations
  • 57 h-Index
1978 …2016

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2016

A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520

Puvvada, S. D., Li, H., Rimsza, L. M., Bernstein, S. H., Fisher, R. I., LeBlanc, M., Schmelz, M., Glinsmann-Gibson, B., Miller, T. P., Maddox, A. M., Friedberg, J. W., Smith, S. M. & Persky, D. O., Jan 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-11 11 p.

Research output: Contribution to journalArticle

17 Scopus citations

Phase I study of single-agent CC-292, a highly selective bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Brown, J. R., Harb, W. A., Hill, B. T., Gabrilove, J., Sharman, J. P., Schreeder, M. T., Barr, P. M., Foran, J. M., Miller, T. P., Burger, J. A., Kelly, K. R., Mahadevan, D., Ma, S., Li, Y., Pierce, D. W., Barnett, E., Marine, J., Miranda, M., Azaryan, A., Yu, X. & 3 others, Nava-Parada, P., Mei, J. & Kipps, T. J., Jan 1 2016, In : Haematologica. 101, 7, p. e295-e298

Research output: Contribution to journalLetter

26 Scopus citations
2015

Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313

Persky, D. O., Miller, T. P., Unger, J. M., Spier, C. M., Puvvada, S., Dino Stea, B., Press, O. W., Constine, L. S., Barton, K. P., Friedberg, J. W., LeBlanc, M. & Fisher, R. I., Aug 8 2015, In : Blood. 125, 2, p. 236-241 6 p.

Research output: Contribution to journalArticle

6 Scopus citations
2014

Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2

Mahadevan, D., Morales, C., Cooke, L. S., Manziello, A., Mount, D. W., Persky, D. O., Fisher, R. I., Miller, T. P. & Qi, W., Jun 3 2014, In : PloS one. 9, 6, e95184.

Research output: Contribution to journalArticle

25 Scopus citations

Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma

Gustafson, H. L., Yao, S., Goldman, B. H., Lee, K., Spier, C. M., LeBlanc, M. L., Rimsza, L. M., Cerhan, J. R., Habermann, T. M., Link, B. K., Maurer, M. J., Slager, S. L., Persky, D. O., Miller, T. P., Fisher, R. I., Ambrosone, C. B. & Briehl, M. M., May 2014, In : American Journal of Hematology. 89, 6, p. 639-645 7 p.

Research output: Contribution to journalArticle

18 Scopus citations

Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma

Barr, P. M., Miller, T. P., Friedberg, J. W., Peterson, D. R., Baran, A. M., Herr, M., Spier, C. M., Cui, H., Roe, D. J., Persky, D. O., Casulo, C., Littleton, J., Schwartz, M., Puvvada, S., Landowski, T. H., Rimsza, L. M., Dorr, R. T., Fisher, R. I., Bernstein, S. H. & Briehl, M. M., Aug 21 2014, In : Blood. 124, 8, p. 1259-1265 7 p.

Research output: Contribution to journalArticle

15 Scopus citations

R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433

Friedberg, J. W., Unger, J. M., Burack, W. R., Gopal, A. K., Raju, R. N., Nademanee, A. P., Kaminski, M. S., Li, H., Press, O. W., Miller, T. P. & Fisher, R. I., Aug 2014, In : British Journal of Haematology. 166, 3, p. 382-389 8 p.

Research output: Contribution to journalArticle

18 Scopus citations
2013

A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine- tositumomab

Press, O. W., Unger, J. M., Rimsza, L. M., Friedberg, J. W., Leblanc, M., Czuczman, M. S., Kaminski, M., Braziel, R. M., Spier, C., Gopal, A. K., Maloney, D. G., Cheson, B. D., Dakhil, S. R., Miller, T. P. & Fisher, R. I., Dec 1 2013, In : Clinical Cancer Research. 19, 23, p. 6624-6632 9 p.

Research output: Contribution to journalArticle

24 Scopus citations

Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment

Qi, W., Spier, C., Liu, X., Agarwal, A., Cooke, L. S., Persky, D. O., Chen, D., Miller, T. P. & Mahadevan, D., Apr 1 2013, In : Leukemia Research. 37, 4, p. 434-439 6 p.

Research output: Contribution to journalArticle

39 Scopus citations

A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213

Bernstein, S. H., Epner, E., Unger, J. M., LeBlanc, M., Cebula, E., Burack, R., Rimsza, L., Miller, T. P. & Fisher, R. I., Jun 1 2013, In : Annals of Oncology. 24, 6, p. 1587-1593 7 p.

Research output: Contribution to journalArticle

76 Scopus citations

Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma

Stiff, P. J., Unger, J. M., Cook, J. R., Constine, L. S., Couban, S., Stewart, D. A., Shea, T. C., Porcu, P., Winter, J. N., Kahl, B. S., Miller, T. P., Tubbs, R. R., Marcellus, D., Friedberg, J. W., Barton, K. P., Mills, G. M., LeBlanc, M., Rimsza, L. M., Forman, S. J. & Fisher, R. I., Jan 1 2013, In : New England Journal of Medicine. 369, 18, p. 1681-1690 10 p.

Research output: Contribution to journalArticle

192 Scopus citations

Examination of the follicular lymphoma international prognostic index (FLIPI) in the national lymphocare study (NLCS): A prospective US patient cohort treated predominantly in community practices

Nooka, A. K., Nabhan, C., Zhou, X., Taylor, M. D., Byrtek, M., Miller, T. P., Friedberg, J. W., Zelenetz, A. D., Link, B. K., Cerhan, J. R., Dillon, H., Sinha, R., Shenoy, P. J., Levy, D., Dawson, K., Hirata, J. H. & Flowers, C. R., Feb 1 2013, In : Annals of Oncology. 24, 2, p. 441-448 8 p., mds429.

Research output: Contribution to journalArticle

35 Scopus citations

Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350

Mahadevan, D., Unger, J. M., Spier, C. M., Persky, D. O., Young, F., Leblanc, M., Fisher, R. I. & Miller, T. P., Jan 15 2013, In : Cancer. 119, 2, p. 371-379 9 p.

Research output: Contribution to journalArticle

74 Scopus citations

Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus 131iodine-tositumomab for previously untreated follicular non-hodgkin lymphoma: SWOG S0016

Press, O. W., Unger, J. M., Rimsza, L. M., Friedberg, J. W., LeBlanc, M., Czuczman, M. S., Kaminski, M., Braziel, R. M., Spier, C., Gopal, A. K., Maloney, D. G., Cheson, B. D., Dakhil, S. R., Miller, T. P. & Fisher, R. I., Jan 20 2013, In : Journal of Clinical Oncology. 31, 3, p. 314-320 7 p.

Research output: Contribution to journalArticle

110 Scopus citations

Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: Correlative analysis from a large North American cooperative group trial

Kanakry, J. A., Li, H., Gellert, L. L., Lemas, M. V., Hsieh, W. S., Hong, F., Tan, K. L., Gascoyne, R. D., Gordon, L. I., Fisher, R. I., Bartlett, N. L., Stiff, P., Cheson, B. D., Advani, R., Miller, T. P., Kahl, B. S., Horning, S. J. & Ambinder, R. F., May 2 2013, In : Blood. 121, 18, p. 3547-3553 7 p.

Research output: Contribution to journalArticle

77 Scopus citations

Radiotherapy is NOT essential to cure diffuse large B-cell non-Hodgkin lymphoma

Puvvada, S. & Miller, T., May 20 2013, In : ONCOLOGY (United States). 27, 5

Research output: Contribution to journalComment/debate

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: A comprehensive analysis from the North American intergroup trial E2496

Evens, A. M., Hong, F., Gordon, L. I., Fisher, R. I., Bartlett, N. L., Connors, J. M., Gascoyne, R. D., Wagner, H., Gospodarowicz, M., Cheson, B. D., Stiff, P. J., Advani, R., Miller, T. P., Hoppe, R. T., Kahl, B. S. & Horning, S. J., Apr 1 2013, In : British Journal of Haematology. 161, 1, p. 76-86 11 p.

Research output: Contribution to journalArticle

71 Scopus citations
2012
47 Scopus citations

AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas

Qi, W., Liu, X., Cooke, L. S., Persky, D. O., Miller, T. P., Squires, M. & Mahadevan, D., Jun 15 2012, In : International Journal of Cancer. 130, 12, p. 2997-3005 9 p.

Research output: Contribution to journalArticle

29 Scopus citations

Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma

Mahadevan, D., Stejskal, A., Cooke, L. S., Manziello, A., Morales, C., Persky, D. O., Fisher, R. I., Miller, T. P. & Qi, W., Apr 15 2012, In : Clinical Cancer Research. 18, 8, p. 2210-2219 10 p.

Research output: Contribution to journalArticle

44 Scopus citations

Effectiveness of first-line management strategies for stage I follicular lymphoma: Analysis of the National Lymphocare Study

Friedberg, J. W., Byrtek, M., Link, B. K., Flowers, C., Taylor, M., Hainsworth, J., Cerhan, J. R., Zelenetz, A. D., Hirata, J. & Miller, T. P., Sep 20 2012, In : Journal of Clinical Oncology. 30, 27, p. 3368-3375 8 p.

Research output: Contribution to journalArticle

96 Scopus citations

Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone

Persky, D. O., Dornan, D., Goldman, B. H., Braziel, R. M., Fisher, R. I., LeBlanc, M., Maloney, D. G., Press, O. W., Miller, T. P. & Rimsza, L. M., Jun 1 2012, In : Haematologica. 97, 6, p. 937-942 6 p.

Research output: Contribution to journalArticle

44 Scopus citations

Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: Report from the National LymphoCare Study

Nabhan, C., Byrtek, M., Taylor, M. D., Friedberg, J. W., Cerhan, J. R., Hainsworth, J. D., Miller, T. P., Hirata, J., Link, B. K. & Flowers, C. R., Oct 1 2012, In : Cancer. 118, 19, p. 4842-4850 9 p.

Research output: Contribution to journalArticle

22 Scopus citations

Reply to "Fc gamma receptor 3a genotype in follicular lymphoma: The end of the story?" Haematologica. 2012;97(11): e45

Persky, D. O., Dornan, D., Goldman, B. H., Braziel, R. M., Fisher, R. I., LeBlanc, M., Maloney, D. G., Press, O. W., Miller, T. P. & Rimsza, L. M., Nov 1 2012, In : Haematologica. 97, 11, p. e46

Research output: Contribution to journalLetter

2011

Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues

Rimsza, L. M., Wright, G., Schwartz, M., Chan, W. C., Jaffe, E. S., Gascoyne, R. D., Campo, E., Rosenwald, A., Ott, G., Cook, J. R., Tubbs, R. R., Braziel, R. M., Delabie, J., Miller, T. P. & Staudt, L. M., Jun 1 2011, In : Clinical Cancer Research. 17, 11, p. 3727-3732 6 p.

Research output: Contribution to journalArticle

51 Scopus citations

Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma

Qi, W., Cooke, L. S., Liu, X., Rimsza, L., Roe, D. J., Persky, A. M. D. O., Miller, T. P. & Mahadevan, D., Apr 1 2011, In : Biochemical Pharmacology. 81, 7, p. 881-890 10 p.

Research output: Contribution to journalArticle

67 Scopus citations
2009

A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108

Stopeck, A. T., Unger, J. M., Rimsza, L. M., Bellamy, W. T., Iannone, M., Persky, D., Leblanc, M., Fisher, R. & Miller, T., Aug 17 2009, In : Leukemia and Lymphoma. 50, 5, p. 728-735 8 p.

Research output: Contribution to journalArticle

83 Scopus citations

Localized large cell lymphoma: Is there any need for radiation therapy?

Persky, D. O. & Miller, T. P., Sep 1 2009, In : Current Opinion in Oncology. 21, 5, p. 401-406 6 p.

Research output: Contribution to journalReview article

18 Scopus citations

Natural history of cns relapse in patients with aggressive non-hodgkin's lymphoma: A 20-year follow-up analysis of swog 8516-the southwest oncology group

Bernstein, S. H., Unger, J. M., LeBlanc, M., Friedberg, J., Miller, T. P. & Fisher, R. I., Jan 1 2009, In : Journal of Clinical Oncology. 27, 1, p. 114-119 6 p.

Research output: Contribution to journalArticle

138 Scopus citations

Reply to M.C. Chamberlain

Bernstein, S. H., Unger, J. M., LeBlanc, M., Friedberg, J., Miller, T. P. & Fisher, R. I., Jul 20 2009, In : Journal of Clinical Oncology. 27, 21, p. e27-e28

Research output: Contribution to journalEditorial

1 Scopus citations
2008

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP

Rimsza, L. M., LeBlanc, M. L., Unger, J. M., Miller, T. P., Grogan, T. M., Persky, D. O., Mattel, R. R., Sabalos, C. M., Seligmann, B., Braziel, R. M., Campo, E., Rosenwald, A., Connors, J. M., Sehn, L. H., Johnson, N. & Gascoyne, R. D., Oct 15 2008, In : Blood. 112, 8, p. 3425-3433 9 p.

Research output: Contribution to journalArticle

111 Scopus citations

Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group Study 0014

Persky, D. O., Unger, J. M., Spier, C. M., Stea, B., LeBlanc, M., McCarty, M. J., Rimsza, L. M., Fisher, R. I. & Miller, T. P., Sep 15 2008, In : Journal of Clinical Oncology. 26, 14, p. 2258-2263 6 p.

Research output: Contribution to journalArticle

174 Scopus citations

Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder

Swinnen, L. J., Leblanc, M., Grogan, T. M., Gordon, L. I., Stiff, P. J., Miller, A. M., Kasamon, Y., Miller, T. P. & Fisher, R. I., Jul 27 2008, In : Transplantation. 86, 2, p. 215-222 8 p.

Research output: Contribution to journalArticle

71 Scopus citations

Stromal gene signatures in large-B-cell lymphomas

Lenz, G., Wright, G., Dave, S. S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., Vose, J., Bast, M., Fu, K., Weisenburger, D. D., Greiner, T. C., Armitage, J. O., Kyle, A., May, L., Gascoyne, R. D., Connors, J. M. & 30 others, Troen, G., Holte, H., Kvaloy, S., Dierickx, D., Verhoef, G., Delabie, J., Smeland, E. B., Jares, P., Martinez, A., Lopez-Guillermo, A., Montserrat, E., Campo, E., Braziel, R. M., Miller, T. P., Rimsza, L. M., Cook, J. R., Pohlman, B., Sweetenham, J., Tubbs, R. R., Fisher, R. I., Hartmann, E., Rosenwald, A., Ott, G., Muller-Hermelink, H. K., Wrench, D., Lister, T. A., Jaffe, E. S., Wilson, W. H., Chan, W. C. & Staudt, L. M., Nov 27 2008, In : New England Journal of Medicine. 359, 22, p. 2313-2323 11 p.

Research output: Contribution to journalArticle

1067 Scopus citations
2007

A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma

Leonard, J. P., Friedberg, J. W., Younes, A., Fisher, D., Gordon, L. I., Moore, J., Czuczman, M., Miller, T., Stiff, P., Cheson, B. D., Forero-Torres, A., Chieffo, N., McKinney, B., Finucane, D. & Molina, A., Jul 2007, In : Annals of Oncology. 18, 7, p. 1216-1223 8 p.

Research output: Contribution to journalArticle

108 Scopus citations

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

Wiestner, A., Tehrani, M., Chiorazzi, M., Wright, G., Gibellini, F., Nakayama, K., Liu, H., Rosenwald, A., Muller-Hermelink, H. K., Ott, G., Chan, W. C., Greiner, T. C., Weisenburger, D. D., Vose, J., Armitage, J. O., Gascoyne, R. D., Connors, J. M., Campo, E., Montserrat, E., Bosch, F. & 10 others, Smeland, E. B., Kvaloy, S., Holte, H., Delabie, J., Fisher, R. I., Grogan, T. M., Miller, T. P., Wilson, W. H., Jaffe, E. S. & Staudt, L. M., Jun 1 2007, In : Blood. 109, 11, p. 4599-4606 8 p.

Research output: Contribution to journalArticle

160 Scopus citations

Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma

Roberts, R. A., Sabalos, C. M., LeBlanc, M. L., Martel, R. R., Frutiger, Y. M., Unger, J. M., Botros, I. W., Rounseville, M. P., Seligmann, B. E., Miller, T. P., Grogan, T. M. & Rimsza, L. M., Oct 1 2007, In : Laboratory Investigation. 87, 10, p. 979-997 19 p.

Research output: Contribution to journalArticle

35 Scopus citations
2006
9 Scopus citations

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

Rimsza, L. M., Roberts, R. A., Campo, E., Grogan, T. M., Bea, S., Salaverria, I., Zettl, A., Rosenwald, A., Ott, G., Muller-Hermelink, H. K., Delabie, J., Fisher, R. I., Unger, J. M., LeBlanc, M., Staudt, L. M., Jaffe, E. S., Gascoyne, R. D., Chan, W. C., Weisenburger, D. D., Greiner, T. & 2 others, Braziel, R. M. & Miller, T. P., Feb 1 2006, In : Blood. 107, 3, p. 1101-1107 7 p.

Research output: Contribution to journalArticle

54 Scopus citations

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

Roberts, R. A., Wright, G., Rosenwald, A. R., Jaramillo, M. A., Grogan, T. M., Miller, T. P., Frutiger, Y., Chan, W. C., Gascoyne, R. D., Ott, G., Muller-Hermelink, H. K., Staudt, L. M. & Rimsza, L. M., Jul 1 2006, In : Blood. 108, 1, p. 311-318 8 p.

Research output: Contribution to journalArticle

67 Scopus citations

Molecular diagnosis of Burkitt's lymphoma

Dave, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P., Boerma, E. J., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., Müller-Hermelink, H. K., Gascoyne, R. D., Delabie, J., Rimsza, L. M., Braziel, R. M., Grogan, T. M., Campo, E., Jaffe, E. S., Dave, B. J., Sanger, W. & 18 others, Bast, M., Vose, J. M., Armitage, J. O., Connors, J. M., Smeland, E. B., Kvaloy, S., Holte, H., Fisher, R. I., Miller, T. P., Montserrat, E., Wilson, W. H., Bahl, M., Zhao, H., Yang, L., Powell, J., Simon, R., Chan, W. C. & Staudt, L. M., Jun 8 2006, In : New England Journal of Medicine. 354, 23, p. 2431-2442 12 p.

Research output: Contribution to journalArticle

648 Scopus citations

Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: Five-year follow-up of Southwest Oncology Group protocol S9911

Press, O. W., Unger, J. M., Braziel, R. M., Maloney, D. G., Miller, T. P., LeBlanc, M. & Fisher, R. I., Sep 1 2006, In : Journal of Clinical Oncology. 24, 25, p. 4143-4149 7 p.

Research output: Contribution to journalArticle

198 Scopus citations
2005

A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis

Tome, M. E., Johnson, D. B. F., Rimsza, L. M., Roberts, R. A., Grogan, T. M., Miller, T. P., Oberley, L. W. & Briehl, M. M., Nov 15 2005, In : Blood. 106, 10, p. 3594-3601 8 p.

Research output: Contribution to journalArticle

73 Scopus citations

In Reply [2]

Miller, T. P. & Grogan, T. M., Dec 1 2005, In : Journal of Clinical Oncology. 23, 35, p. 9030-9031 2 p.

Research output: Contribution to journalLetter

New treatment options have changed the survival of patients with follicular lymphoma

Fisher, R. L., LeBlanc, M., Press, O. W., Maloney, D. G., Unger, J. M. & Miller, T. P., Dec 1 2005, In : Journal of Clinical Oncology. 23, 33, p. 8447-8452 6 p.

Research output: Contribution to journalArticle

332 Scopus citations

Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma

Czuczman, M. S., Thall, A., Witzig, T. E., Vose, J. M., Younes, A., Emmanouilides, C., Miller, T. P., Moore, J. O., Leonard, J. P., Gordon, L. I., Sweetenham, J., Alkuzweny, B., Finucane, D. M. & Leigh, B. R., Dec 1 2005, In : Journal of Clinical Oncology. 23, 19, p. 4390-4398 9 p.

Research output: Contribution to journalArticle

140 Scopus citations

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures

Mahadevan, D., Spier, C., Della Croce, K., Miller, S., George, B., Riley, C., Warner, S., Grogan, T. M. & Miller, T. P., Dec 1 2005, In : Molecular Cancer Therapeutics. 4, 12, p. 1867-1879 13 p.

Research output: Contribution to journalArticle

72 Scopus citations
2004

Diffuse aggressive lymphoma.

Fisher, R. I., Miller, T. P. & O'Connor, O. A., 2004, In : Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. p. 221-236 16 p.

Research output: Contribution to journalReview article

Open Access
80 Scopus citations

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: A follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

Rimsza, L. M., Roberts, R. A., Miller, T. P., Unger, J. M., LeBlanc, M., Braziel, R. M., Weisenberger, D. D., Chan, W. C., Muller-Hermelink, H. K., Jaffe, E. S., Gascoyne, R. D., Campo, E., Fuchs, D. A., Spier, C. M., Fisher, R. I., Delabie, J., Rosenwald, A., Staudt, L. M. & Grogan, T. M., Jun 1 2004, In : Blood. 103, 11, p. 4251-4258 8 p.

Research output: Contribution to journalArticle

216 Scopus citations

Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

Dave, S. S., Wright, G., Tan, B., Rosenwald, A., Gascoyne, R. D., Chan, W. C., Fisher, R. I., Braziel, R. M., Rimsza, L. M., Grogan, T. M., Miller, T. P., LeBlanc, M., Greiner, T. C., Weisenburger, D. D., Lynch, J. C., Vose, J., Armitage, J. O., Smeland, E. B., Kvaloy, S., Holte, H. & 20 others, Delabie, J., Connors, J. M., Lansdorp, P. M., Ouyang, Q., Lister, T. A., Davies, A. J., Norton, A. J., Muller-Hermelink, H. K., Ott, G., Campo, E., Montserrat, E., Wilson, W. H., Jaffe, E. S., Simon, R., Yang, L., Powell, J., Zhao, H., Goldschmidt, N., Chiorazzi, M. & Staudt, L. M., Nov 18 2004, In : New England Journal of Medicine. 351, 21, p. 2159-2169 11 p.

Research output: Contribution to journalArticle

1029 Scopus citations